MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Sotera Health Company P/S Ratio 2011-2026 | SHC
Annual P/S Ratio Sotera Health Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.09 | 3.16 | 4.64 | 4.67 | 6.45 | 9.07 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.07 | 3.16 | 5.35 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
6.64 | $ 113.95 | -0.77 % | $ 34.6 B |  USA |
 |
CareDx, Inc
CDNA
|
2.61 | $ 17.3 | -2.92 % | $ 922 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
6.87 | $ 16.4 | 0.61 % | $ 176 M |  China |
 |
Co-Diagnostics
CODX
|
9.4 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | USA |
 |
National Research Corporation
NRC
|
2.29 | $ 17.24 | -0.52 % | $ 386 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
1.92 | $ 168.88 | 0.33 % | $ 8.37 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | USA |
 |
Castle Biosciences
CSTL
|
2.14 | $ 24.9 | 0.67 % | $ 692 M | USA |
 |
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | USA |
|
Biodesix
BDSX
|
1.29 | $ 15.24 | -0.78 % | $ 1.98 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.8 | $ 26.95 | -0.97 % | $ 20 B |  Niderland |
 |
Danaher Corporation
DHR
|
6.09 | $ 191.24 | -0.44 % | $ 136 B | USA |
 |
DexCom
DXCM
|
5.47 | $ 64.09 | 1.39 % | $ 25 B | USA |
 |
Fulgent Genetics
FLGT
|
1.65 | $ 16.44 | 0.12 % | $ 497 M | USA |
 |
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B | Niderland |
 |
Guardant Health
GH
|
13.7 | $ 90.19 | 0.59 % | $ 11.3 B | USA |
 |
Anixa Biosciences
ANIX
|
0.718 | $ 2.61 | 0.77 % | $ 84.7 K | USA |
 |
Biomerica
BMRA
|
1.35 | $ 2.13 | -2.07 % | $ 4.89 M | USA |
 |
BioNano Genomics
BNGO
|
0.279 | $ 1.13 | -1.7 % | $ 6.15 M | USA |
 |
ICON Public Limited Company
ICLR
|
3.25 | $ 108.32 | -1.18 % | $ 8.93 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
0.19 | $ 1.97 | - | $ 8.72 M | USA |
 |
Illumina
ILMN
|
3.75 | $ 127.78 | 0.03 % | $ 20.3 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.71 | $ 275.15 | 0.21 % | $ 22.9 B | USA |
 |
Lantheus Holdings
LNTH
|
3.32 | $ 76.09 | 0.26 % | $ 5.14 B | USA |
 |
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | USA |
 |
Medpace Holdings
MEDP
|
5.12 | $ 497.15 | 0.23 % | $ 14.3 B | USA |
 |
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | USA |
 |
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
6 | - | - | $ 19.8 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.11 | $ 199.79 | 0.37 % | $ 22.2 B | USA |
 |
Myriad Genetics
MYGN
|
0.496 | $ 4.7 | 0.64 % | $ 435 M | USA |
 |
ENDRA Life Sciences
NDRA
|
1.59 K | $ 4.74 | - | $ 3.73 M | USA |
 |
NeoGenomics
NEO
|
2.04 | $ 8.04 | 0.25 % | $ 1.03 B | USA |
 |
Neogen Corporation
NEOG
|
1.14 | $ 9.63 | 0.73 % | $ 2.09 B | USA |
 |
Natera
NTRA
|
6.47 | $ 206.6 | 0.84 % | $ 20.3 B | USA |
 |
Pacific Biosciences of California
PACB
|
3.11 | $ 1.38 | -2.82 % | $ 414 M | USA |
 |
Precipio
PRPO
|
1.6 | $ 25.98 | - | $ 41.7 M | USA |
 |
Personalis
PSNL
|
3 | $ 6.38 | -3.04 % | $ 378 M | USA |
 |
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | USA |